Send to

Choose Destination
Cell Mol Biol (Noisy-le-grand). 2018 May 15;64(6):48-52.

Visfatin increases miR-21 to promote migration in HCC.

Author information

The fourth inpatient area of digestive department, Central Hospital of Suining, Suining 629000, China.
Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, China.


Hepatocellular carcinoma (HCC) is a common human malignancy. In this study, we aimed to investigate the serum levels of visfatin and miR-21 in HCC patients, to analysis the relationship between the pathological features and the plasma level of visfatin or miR-21, and to explore the roles of visfatin and miR-21 in migration of HCC cells. Our results showed that the serum levels of visfatin and miR-21 were significant higher in HCC patients than healthy subjects. The diagnostic sensitivity of serum visfatin was 82.5% and the specificity was 65.0%. The serum visfatin was significantly associated with the histology and metastasis. Visfatin induced miR-21 expression and cell migration in HepG2 cells. Transfection of miR-21 inhibitor suppressed the visfatin-induced migration in HCC cells. These results suggested that visfatin induced HCC cell migration via upregulation of miR-21, which provides a novel basis for the diagnosis of HCC.


HCC; HepG2; Metastasis.; Visfatin; miR-21

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center